MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation ROCE Ratio 2011-2026 | PMD
Annual ROCE Ratio Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.78 | -10.05 | 1.71 | -48.48 | 13.82 | 36.39 | 36.61 | 49.23 | 7.83 | 22.9 | 41.99 | 41.0 | 50.36 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.36 | -48.48 | 15.35 |
Quarterly ROCE Ratio Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.51 | -54.49 | -43.4 | -24.66 | -27.86 | -16.16 | -14.46 | -6.14 | -0.08 | 9.17 | 13.62 | 8.55 | -0.31 | -17.63 | -45.63 | -48.48 | -43.22 | -24.03 | 10.28 | 17.82 | 29.58 | 32.95 | 36.04 | 40.59 | 42.9 | 43.58 | 41.79 | 43.81 | 56.65 | 70.96 | 76.97 | 64.78 | 42.45 | 20.87 | 8.72 | 12.6 | 19.09 | 24.07 | 31.3 | 36.54 | 37.49 | 41.96 | 45.79 | 46.48 | 42.2 | 40.78 | 41.5 | 43.98 | 46.61 | 50.24 | 51.35 | 52.58 | 16.38 | 15.93 | 13.5 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 76.97 | -54.49 | 18.28 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.95 | -1.97 % | $ 957 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 115.26 | -0.19 % | $ 35 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 166.68 | -4.15 % | $ 8.26 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 25.08 | 0.95 % | $ 697 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 191.97 | 0.44 % | $ 137 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
DexCom
DXCM
|
33.2 | $ 62.95 | 1.17 % | $ 24.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.54 | -1.66 % | $ 500 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
440.3 | $ 90.17 | -3.9 % | $ 11.3 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 16.03 | -1.06 % | $ 173 M |  China |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 110.02 | -3.65 % | $ 9.07 B |  Irlanda |
 |
Illumina
ILMN
|
-35.1 | $ 127.46 | 0.06 % | $ 20.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 170.2 | -1.77 % | $ 29.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 274.39 | 0.24 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 76.15 | 0.07 % | $ 5.14 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 496.01 | -0.47 % | $ 14.3 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 265.73 | 0.46 % | $ 26.1 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.56 | -2.72 % | $ 3.59 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 7.94 | -0.73 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.46 | 0.53 % | $ 2.05 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.42 | 1.52 % | $ 390 M | USA |
|
Biodesix
BDSX
|
-41.6 | $ 15.96 | 5.91 % | $ 2.07 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 204.3 | -1.77 % | $ 20.1 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.42 | 5.6 % | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.17 | 0.2 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-8.25 | $ 26.25 | 3.35 % | $ 42.1 M | USA |
 |
Personalis
PSNL
|
-33.64 | $ 6.59 | 0.15 % | $ 390 M | USA |
 |
RadNet
RDNT
|
5.69 | $ 55.09 | 0.55 % | $ 4.14 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.81 | -1.3 % | $ 284 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Sotera Health Company
SHC
|
70.91 | $ 14.86 | -0.67 % | $ 4.22 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.3 | 32.43 % | $ 2.66 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.79 | 17.76 % | $ 118 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 485.83 | -1.15 % | $ 183 B | USA |